Pfizer has partnered with Sciwind Biosciences for a new type 2 diabetes drug. The deal could be worth up to 495 million dollars. This drug,...

LLY stock today: Eli Lilly's stock saw a significant jump following impressive fourth-quarter results and a strong 2026 financial forecast....

Eli Lilly and Novo Nordisk are in a race to dominate India's booming obesity drug market. They are using aggressive marketing, doctor outre...

Novo Nordisk's popular weight-loss drug Wegovy is now available as a pill in the US. The US Food and Drug Administration has approved the o...

Eli Lilly has reduced the cost of its popular obesity drug Zepbound for American patients. This move aims to make the treatment more access...

A new pill, Orforglipron, is set to revolutionize weight loss and diabetes treatment. This daily pill, developed by Eli Lilly, has shown si...

Wall Street estimates the weight-loss drug market to be worth $150 billion by 2030, with Lilly and Novo together controlling the majority o...

Pfizer has agreed to acquire obesity drug developer Metsera for up to $86.25 a share, surpassing Novo Nordisk's final offer. This move mark...

Eli Lilly's Mounjaro drug has become India's top seller for October as sales reached one billion rupees. This anti-obesity medication helps...

Several pharmaceutical companies are now selling drugs directly to U.S. patients and offering significant discounts, responding to Presiden...

Shares of Novo Nordisk, the fourth-largest healthcare company on the STOXX index, climbed 3.1% after the company said Wegovy cut the risk o...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also strengthening it...

Novo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy conta...

Ozempic, a popular weight loss drug, may cause an unusual side effect. This effect is called 'Ozempic-feet'. It involves sagging skin on th...

Olympic sponsors saw a significant branding boost from the Paris Games after the Tokyo event's disruptions. The French capital attracted 11...

Shares were off about 1% at $696.82 after gaining about 11% in January, making Lilly the eighth largest company in the U.S. by market capit...

A drug overdose is bad news for your beauty.